Home/AstraZeneca/Pascal Soriot
PS

Pascal Soriot

Executive Director and Chief Executive Officer

AstraZeneca

AstraZeneca Pipeline

DrugIndicationPhase
Datopotamab deruxtecanNon-small cell lung cancer (NSCLC)Phase III
Volrustomig1L Non-small cell lung cancerPhase III
CamizestrantER+ Breast CancerPhase III
BaxdrostatResistant HypertensionPhase III
AcoramidisATTR CardiomyopathyRegulatory Review
TozorakimabCOPDPhase III
EplontersenATTR PolyneuropathyPhase III / Marketed
AZD7789Advanced Solid TumorsPhase I/II